157 related articles for article (PubMed ID: 33513346)
1. Subversion of calreticulin exposure as a strategy of immune escape.
Kroemer G; Zitvogel L
Cancer Cell; 2021 Apr; 39(4):449-451. PubMed ID: 33513346
[TBL] [Abstract][Full Text] [Related]
2. Stanniocalcin 1 is a phagocytosis checkpoint driving tumor immune resistance.
Lin H; Kryczek I; Li S; Green MD; Ali A; Hamasha R; Wei S; Vatan L; Szeliga W; Grove S; Li X; Li J; Wang W; Yan Y; Choi JE; Li G; Bian Y; Xu Y; Zhou J; Yu J; Xia H; Wang W; Alva A; Chinnaiyan AM; Cieslik M; Zou W
Cancer Cell; 2021 Apr; 39(4):480-493.e6. PubMed ID: 33513345
[TBL] [Abstract][Full Text] [Related]
3. Calreticulin mutation does not contribute to disease progression in essential thrombocythemia by inhibiting phagocytosis.
Daitoku S; Takenaka K; Yamauchi T; Yurino A; Jinnouchi F; Nunomura T; Eto T; Kamimura T; Higuchi M; Harada N; Saito N; Miyamoto T; Iwasaki H; Akashi K
Exp Hematol; 2016 Sep; 44(9):817-825.e3. PubMed ID: 27185380
[TBL] [Abstract][Full Text] [Related]
4. Identification of calreticulin as a marker for phagocytosis of apoptotic cells in Drosophila.
Kuraishi T; Manaka J; Kono M; Ishii H; Yamamoto N; Koizumi K; Shiratsuchi A; Lee BL; Higashida H; Nakanishi Y
Exp Cell Res; 2007 Feb; 313(3):500-10. PubMed ID: 17137576
[TBL] [Abstract][Full Text] [Related]
5. A Calreticulin Tail: C-terminal Mutants of Calreticulin Allow Cancer Cells to Evade Phagocytosis.
Kaur A; Raghavan M
Mol Cell; 2020 Feb; 77(4):683-685. PubMed ID: 32084350
[TBL] [Abstract][Full Text] [Related]
6. Biphasic Increases of Cell Surface Calreticulin Following Treatment with Mitoxantrone.
Azuma Y; Suzuki K; Higai K; Matsumoto K; Tada S
Biol Pharm Bull; 2020 Oct; 43(10):1595-1599. PubMed ID: 32727970
[TBL] [Abstract][Full Text] [Related]
7. Macrophages eat cancer cells using their own calreticulin as a guide: roles of TLR and Btk.
Feng M; Chen JY; Weissman-Tsukamoto R; Volkmer JP; Ho PY; McKenna KM; Cheshier S; Zhang M; Guo N; Gip P; Mitra SS; Weissman IL
Proc Natl Acad Sci U S A; 2015 Feb; 112(7):2145-50. PubMed ID: 25646432
[TBL] [Abstract][Full Text] [Related]
8. Calreticulin exposure orchestrates innate immunosurveillance.
Guilbaud E; Kroemer G; Galluzzi L
Cancer Cell; 2023 Jun; 41(6):1014-1016. PubMed ID: 37207656
[TBL] [Abstract][Full Text] [Related]
9. TNT-Induced Phagocytosis: Tunneling Nanotubes Mediate the Transfer of Pro-Phagocytic Signals From Apoptotic to Viable Cells.
Bittins M; Wang X
J Cell Physiol; 2017 Sep; 232(9):2271-2279. PubMed ID: 27591547
[TBL] [Abstract][Full Text] [Related]
10. Molecular determinants of immunogenic cell death: surface exposure of calreticulin makes the difference.
Chaput N; De Botton S; Obeid M; Apetoh L; Ghiringhelli F; Panaretakis T; Flament C; Zitvogel L; Kroemer G
J Mol Med (Berl); 2007 Oct; 85(10):1069-76. PubMed ID: 17891368
[TBL] [Abstract][Full Text] [Related]
11. Immunosuppression by Mutated Calreticulin Released from Malignant Cells.
Liu P; Zhao L; Loos F; Marty C; Xie W; Martins I; Lachkar S; Qu B; Waeckel-Énée E; Plo I; Vainchenker W; Perez F; Rodriguez D; López-Otin C; van Endert P; Zitvogel L; Kepp O; Kroemer G
Mol Cell; 2020 Feb; 77(4):748-760.e9. PubMed ID: 31785928
[TBL] [Abstract][Full Text] [Related]
12. Relative contribution of c1q and apoptotic cell-surface calreticulin to macrophage phagocytosis.
Verneret M; Tacnet-Delorme P; Osman R; Awad R; Grichine A; Kleman JP; Frachet P
J Innate Immun; 2014; 6(4):426-34. PubMed ID: 24557008
[TBL] [Abstract][Full Text] [Related]
13. Calreticulin is the dominant pro-phagocytic signal on multiple human cancers and is counterbalanced by CD47.
Chao MP; Jaiswal S; Weissman-Tsukamoto R; Alizadeh AA; Gentles AJ; Volkmer J; Weiskopf K; Willingham SB; Raveh T; Park CY; Majeti R; Weissman IL
Sci Transl Med; 2010 Dec; 2(63):63ra94. PubMed ID: 21178137
[TBL] [Abstract][Full Text] [Related]
14. Calreticulin exposure increases cancer immunogenicity.
Clarke C; Smyth MJ
Nat Biotechnol; 2007 Feb; 25(2):192-3. PubMed ID: 17287754
[No Abstract] [Full Text] [Related]
15. Calreticulin exposure dictates the immunogenicity of cancer cell death.
Obeid M; Tesniere A; Ghiringhelli F; Fimia GM; Apetoh L; Perfettini JL; Castedo M; Mignot G; Panaretakis T; Casares N; Métivier D; Larochette N; van Endert P; Ciccosanti F; Piacentini M; Zitvogel L; Kroemer G
Nat Med; 2007 Jan; 13(1):54-61. PubMed ID: 17187072
[TBL] [Abstract][Full Text] [Related]
16. ERP57 membrane translocation dictates the immunogenicity of tumor cell death by controlling the membrane translocation of calreticulin.
Obeid M
J Immunol; 2008 Aug; 181(4):2533-43. PubMed ID: 18684944
[TBL] [Abstract][Full Text] [Related]
17. Programmed cell removal by calreticulin in tissue homeostasis and cancer.
Feng M; Marjon KD; Zhu F; Weissman-Tsukamoto R; Levett A; Sullivan K; Kao KS; Markovic M; Bump PA; Jackson HM; Choi TS; Chen J; Banuelos AM; Liu J; Gip P; Cheng L; Wang D; Weissman IL
Nat Commun; 2018 Aug; 9(1):3194. PubMed ID: 30097573
[TBL] [Abstract][Full Text] [Related]
18. Surface-exposed and soluble calreticulin: conflicting biomarkers for cancer prognosis.
Kepp O; Liu P; Zhao L; Plo I; Kroemer G
Oncoimmunology; 2020 Jul; 9(1):1792037. PubMed ID: 32923154
[TBL] [Abstract][Full Text] [Related]
19. A siRNA-Assisted Assembly Strategy to Simultaneously Suppress "Self" and Upregulate "Eat-Me" Signals for Nanoenabled Chemo-Immunotherapy.
Zhang Y; Zhang Z; Li S; Zhao L; Li D; Cao Z; Xu X; Yang X
ACS Nano; 2021 Oct; 15(10):16030-16042. PubMed ID: 34544242
[TBL] [Abstract][Full Text] [Related]
20. Surface-exposed calreticulin in the interaction between dying cells and phagocytes.
Martins I; Kepp O; Galluzzi L; Senovilla L; Schlemmer F; Adjemian S; Menger L; Michaud M; Zitvogel L; Kroemer G
Ann N Y Acad Sci; 2010 Oct; 1209():77-82. PubMed ID: 20958319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
